Back

Differential effects of Tafamidis on cardiac remodelling in transthyretin amyloid cardiomyopathy: evidence from contemporary imaging data

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Multimodality cardiac computed tomography and cardiovascular magnetic resonance in pericardial and myocardial disease Imaging of Heart Failure ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Adeeb Jirjis

Liverpool Hospital, Sydney (Australia)

6 More presentations in this session

Presentation thumbnail
Characterising patients and lesions with plaque progression despite high-intensity LDL-C-lowering therapy: a multimodality serial intracoronary imaging study from the IBIS-4 and PACMAN-AMI trials
Doctor R. Kakizaki (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
Multimodality pericardial phenotype on CT and CMR predicts treatment failure in inflammatory and constrictive pericardial syndromes
Doctor A. Tawfek (Cardiff, GB)
Presentation thumbnail
Prognostic value of quantitative SPECT/CT metrics in transthyretin amyloid cardiomyopathy
Doctor G. Tersalvi (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Diagnostic utility of spectral computed tomography in acute myocardial damage without obstructive coronary disease: the CADAMI-SPECTRAL study
Doctor C. Herrera (Salamanca, ES)
Abstract Slides Video
Presentation thumbnail
Border zone channel mass predicts ventricular arrhythmias independently of LVEF in ICD patients
Doctor J. Lubian Esplugues (Cadiz, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Multimodality cardiac computed tomography and cardiovascular magnetic resonance in pericardial and myocardial disease

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Imaging-guided risk stratification in transthyretin amyloidosis
28 August 2026
thumbnail
Congress Presentation
Tafamidis in patients with amyloid cardiomyopathy: a systematic review and meta-analysis of 14 studies.
1 September 2025
thumbnail
Congress Presentation
Characteristics and treatment of contemporary real-world patients with cardiac transthyretin amyloidosis: a retrospective, multicenter, observational study
11 May 2024
thumbnail
Congress Presentation
Serial changes of 99mTc- pyrophosphate uptake in patients with hereditary transthyretin amyloid cardiomyopathy treated with tafamidis
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources